Nicholas Thompson, DO
Family Medicine · Tulsa, OKNPI 1629334701
Payments from drug & device makers
Across 64 payments — averaging $29.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$568
- Boehringer Ingelheim$243
- AstraZeneca$194
- AbbVie$139
- Pfizer$88
- Takeda Pharmaceuticals U.S.A., Inc.$79
- plus $607 from 26 others
What the payments were for
- Travel & lodging$42622%
- Food & beverage$1,49178%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 8 | $568 |
| Boehringer Ingelheim | 2 | $243 |
| AstraZeneca | 5 | $194 |
| AbbVie | 7 | $139 |
| Pfizer | 2 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $79 |
| Novo Nordisk | 5 | $78 |
| Lilly USA, LLC | 3 | $61 |
| Bayer | 2 | $37 |
| Bioventus LLC | 2 | $33 |
| Baxter Healthcare | 1 | $31 |
| Vertex | 1 | $29 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Innovation Technologies Inc | 1 | $26 |
| Astellas Pharma US Inc | 1 | $24 |
| Zimmer Biomet | 1 | $20 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Exact Sciences | 1 | $17 |
| Amgen | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Dynavax Technologies Corporation | 1 | $15 |
| RGH Enterprises LLC | 1 | $15 |
| Abbott | 1 | $13 |
| Zyla Life Sciences, Inc. | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Mallinckrodt Enterprises LLC | 1 | $12 |
| Idorsia Pharmaceuticals US Inc | 1 | $12 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,918 in reported general payments places this provider in the 70th percentile of 1,730 family medicine providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 79 | $636 |
| Gabapentin | 78 | $502 |
| Diclofenac Sodium | 36 | $472 |
| Prednisone | 124 | $205 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 26 | $200 |
| Methylprednisolone | 15 | $176 |
| Cyclobenzaprine Hcl | 28 | $170 |
| Tramadol Hcl | 14 | $92 |
| Diazepam | 18 | $16 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Tulsa
- Jeffrey ChasteenTulsa$820K
- Brooke DunlavyTulsa$572K
- Geoffrey PlumleeTulsa$297K
- Jonathan McGheeTulsa$231K
- Kimberly HuttonTulsa$76K
- Sarah HallTulsa$52K
- Larissa GiulianoTulsa$36K
- Candy TingTulsa$28K
- Scott GhereTulsa$27K
- Michael MaddoxTulsa$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.